KCT0007576进行中（未招募）未知
Application and Effectiveness Evaluation of 3S-BIS (3S Business Intelligence Systems) Simulation Program to Improve Visiting Nursing Business Capabilities of Nursing Students
试验速览
- 阶段
- 未知
- 状态
- 进行中（未招募）
- 入组人数
- 56
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional Study
入排标准
- 年龄范围
- 19(Year) 至 o Limit（—）
- 性别
- All
入选标准
- •The subjects of the study are nursing college students in the 3rd and 4th grades enrolled in the nursing department of nursing.
排除标准
- •A person who does not meet the selection criteria
研究者
相似试验
进行中（未招募）
不适用
A Phase 3 Study to Evaluate the Efficacy and Safety of TAK-390MR (60 mg QD and 90 mg QD) and an Active Comparator, Lansoprazole (30 mgQD) on Healing of Erosive EsophagitisEUCTR2005-001187-31-CZTAP Pharmaceutical Products Inc.1,950
进行中（未招募）
不适用
A Phase 3 Study to Evaluate the Efficacy and Safety of TAK-390MR (60 mg QD and 90 mg QD) and an Active Comparator, Lansoprazole (30 mgQD) on Healing of Erosive EsophagitisErosive esophagitisEUCTR2005-001187-31-LTTAP Pharmaceutical Products Inc.1,950
进行中（未招募）
不适用
A Study to Test the Effect and Safety of Brodalumab Compared With Placebo and Ustekinumab and the Results of Changing Strength or Frequency of Brodalumab in People with Moderate to Severe Plaque Psoriasis: AMAGINE-3Moderate to severe plaque psoriasisMedDRA version: 14.1Level: PTClassification code 10037153Term: PsoriasisSystem Organ Class: 10040785 - Skin and subcutaneous tissue disordersEUCTR2012-000667-24-LVAmgen Inc.1,800
进行中（未招募）
不适用
A Study to Test the Effect and Safety of Brodalumab Compared With Placebo and Ustekinumab and the Results of Changing Strength or Frequency of Brodalumab in People with Moderate to Severe Plaque Psoriasis: AMAGINE-2EUCTR2012-000656-34-PLAmgen Inc.1,800
进行中（未招募）
1 期
A Study to Test the Effect and Safety of Brodalumab Compared With Placebo and Ustekinumab and the Results of Changing Strength or Frequency of Brodalumab in People with Moderate to Severe Plaque Psoriasis: AMAGINE-2EUCTR2012-000656-34-CZAmgen Inc.1,800